Viba Therapeutics Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Viba Therapeutics General Information
Description
Developer of humanized monoclonal antibody therapeutics designed to treat of solid tumors. The company's therapeutics initiate and drive the progression and metastasis of numerous malignancies, including breast, pancreatic, ovarian, prostate and colorectal cancer, enabling healthcare providers to treat their patients and improve their lives.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 1700 Owens Street
- Suite 515
- San Francisco, CA 94158
- United States
Viba Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Sep-2018 | 00.000 | Completed | Out of Business | ||
| 1. Early Stage VC | 26-Apr-2016 | 00.000 | 00.000 | Completed | Startup |